from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3682/ponA2

LFCtreatmentdescriptionclass of inhibitor

-1.922

Amikacinug/mL Amikacintranslation

-0.370

Cap5-10ug/mL Capreomycintranslation

-1.166

Rox10-50 ug/mL Roxithromycintranslation

-0.089

SM2-5 ug/mL Streptomycintranslation

-2.138

Tet5-10 ug/mL Tetracyclinetranslation

-1.460

Rif0.2-5ug/mL Rifampicintranscription

-1.405

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.566

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.118

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.750

CPZ10-50 ug/mL Chlorpromazinerespiration

0.702

Clofazimine10-13 ug/mL Clofaziminerespiration

0.934

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.491

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.362

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.596

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.971

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.873

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.701

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.376

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.362

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.924

KCN5-20 ug/mL Potassium cyaniderespiration

0.164

NaN30.2-2 mM Sodium aziderespiration

0.338

Nigericin50 uM Nigericinrespiration

-1.106

TRC10-150 ug/mL Triclosanrespiration

-0.504

TRZ10-25 ug/mL Thioridazinerespiration

-1.410

Valinomycin0.5-10 uM Valinomycinrespiration

1.023

ZnSO42 mM ZnSO4respiration

0.246

menadione6-10 ug/mL Menadionerespiration

0.232

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.086

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.226

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.278

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.666

NRP_1Non-replicating persistence stage 1dosRassociated

1.185

Amp0.2mg/mL AmpicillincellWall

0.025

Cephalexin20-100 ug/mL CephalexincellWall

0.998

Cerulenin0.32-5 ug/mL CerulenincellWall

0.151

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.619

EMB10-20 ug/mL EthambutolcellWall

1.308

Eta12-40 ug/mL EthionamidecellWall

1.095

INH0.2-0.4 ug/mL IsoniazidcellWall

1.080

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.239

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.175

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.076

BZA0.12 mg/mL BenzamidearomaticAmides

-0.527

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.847

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.420

H2O24 mM hydrogen peroxideDNAdamaging

0.526

Levo10 ug/mL LevofloxacinDNAdamaging

0.791

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.124

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.014

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.427

UVUV-irradiationDNAdamaging

-1.261

ARP41-4 ug/mL Antitubercular compound ARP4?

0.274

Antimycin12.5-50 ug/mL Antimycin A?

-0.097

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.099

PA_110-50 ug/mL Antitubercular compound PA-1?

0.034

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.468

PA8240.2-2 ug/mL PA-824?

0.326

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.208

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.235

Verapamil50 uM Verapamil?

-0.426

mercaptoethanol2 mM 2-Mercaptoethanol?

0.473

methoxatin10-20 ug/mL Methoxatin?